The US insulin delivery devices market — the commercial ecosystem for insulin pens, pumps, automated delivery systems, syringes, and smart delivery platforms serving America's thirty-seven million diabetic patients — represents one of healthcare's most commercially significant and innovation-driven device markets, with the US Insulin Delivery Devices Market reflecting the American...